Recently, FDA announced that it would start its Expedited Access Pathway (EAP) program on April 15, a year after it was proposed.

EAP Program by the FDA is to:

  • Speed qualifying devices to patients without compromising FDA’s high standards for safety and effectiveness.
  • The program will be available to sponsors from April 15.
  • The timeline to respond to such requests is 30 days and if the FDA asks for additional information, the decision cannot be delayed by no later than 30 more days.
  • Being an EAP designated project will grant early collaboration for sponsor with CDRH staff to develop a Data Development Plan with the agency.
  • The Data Development Plan will allow sponsors to understand the type of data expected and also reduce the burden of premarket data collection to postmarket surveillance.
  • EAP designation may also tilt the risk-benefit balance in favor of approval if there is a strong unmet need for the device.
  • If enough information is not provided within this timeframe, FDA will deny the EAP request.

MDD Online

Other News

Indian Govt Notifies New Norms to Regulate Medical Devices

On February 2, 2017 The Ministry of Health and Family Welfare has announced Medical Devices Rules, 2017 that separates regulatory norms for manufacturing medical devices from drugs. The rules will come into effect from January […]

Read More

Maharashtra FDA Asks Blood Banks to Submit License Renewal Applications

Maharashtra Food and Drug Administration (FDA) has directed all 306 blood banks in the state to submit applications of renewal of licenses by 31st December 2016 to carry out timely inspections and approvals. There are […]

Read More

Indian Syringe and Needle Market 2015-2020

Indian syringes and needles market is expected to grow at a CAGR of 15% by 2020. This growth is mainly because of India’s large pool of patients, increase in healthcare expenditure, increase in healthcare awareness […]

Read More

FSSAI Drafts Safety Regulations for Nutraceuticals & Food Supplements

The Ministry of Health’s Food Safety Standards Authority of India has come out with quality and safety standards to regulate the standards and quality of health supplements, nutraceuticals, food (special dietary care, medicinal purpose, functional […]

Read More

FSSAI Proposes New Rules for Health Supplement misabelling

On Monday, Indian food safety watchdog the Food Safety and Standards Authority of India (FSSAI) announced that health supplements cannot be sold as medicines at all and also fixed the permissible limits of various ingredients […]

Read More

More Than Half of Women Plan to Buy Natural Beauty Products

Now a new survey shows that, natural products continue to remain top of mind for many women when it comes to the personal care beauty products. The second annual Green Beauty Barometer survey questioned more […]

Read More

Korean Entrepreneurs to Venture into Indian Cosmetics Market

The United States remains the biggest market for Korean cosmetic products and nowadays Korean investors are venturing into Indian cosmetic market. The Korea Trade Investment Promotion Agency (KOTRA) launched at least 10 Korean cosmetics brands […]

Read More

Meet Us at The Medical Device Regulatory Summit in Mumbai

The first Medical Device Regulatory Summit in India is being held at Holiday Inn Mumbai International Airport on 29 November 2016. Morulaa HealthTech is pleased to partner at this event. Medical Device Regulatory Summit 2016, […]

Read More